Marinus Pharmaceuticals Inc (MRNS)
1.33
-0.02
(-1.48%)
USD |
NASDAQ |
Jun 21, 16:00
1.33
0.00 (0.00%)
After-Hours: 20:00
Marinus Pharmaceuticals Gross Profit (TTM): 25.80M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 25.80M |
December 31, 2023 | 29.06M |
September 30, 2023 | 29.62M |
June 30, 2023 | 25.03M |
Date | Value |
---|---|
March 31, 2023 | 21.13M |
December 31, 2022 | 25.14M |
September 30, 2022 | 19.79M |
June 30, 2022 | 26.13M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
19.79M
Minimum
Sep 2022
29.62M
Maximum
Sep 2023
25.21M
Average
25.47M
Median
Gross Profit (TTM) Benchmarks
Arcutis Biotherapeutics Inc | 98.93M |
Heron Therapeutics Inc | 75.40M |
Pfizer Inc | 31.64B |
Gritstone Bio Inc | -- |
Actinium Pharmaceuticals Inc | -- |